Phospholipase A2 activating protein (PLAA) is required for 1α,25(OH)2D3 signaling in growth plate chondrocytes

作者: Z. Schwartz , E.J. Graham , L. Wang , S. Lossdörfer , I. Gay

DOI: 10.1002/JCP.20212

关键词:

摘要: Phospholipase A 2 (PLA ) is pivotal in the rapid membrane-mediated actions of 1,25-dihydroxyvitamin D3 [1α,25(OH) D 3 ]. Microarray analysis indicated that PLA activating protein (PLAA) mRNA upregulated 6-fold before rat growth plate cells exhibit 1α,25(OH) -dependent kinase C (PKC) increases, suggesting it plays an important role 's mechanism action. PLAA was confirmed -responsive zone (prehypertrophic and upper hypertrophic cell zones) chondrocytes by RT-PCR Northern blot vitro situ hybridization vivo. shown Western immunohistochemistry. PLAAs signaling evaluated cultures using peptide. Arachidonic acid release increased as -specific activity plasma membranes matrix vesicles. PKCa, but not PKCβ, PKCe, or PKCζ, increased. effect comparable to 1 α,25(OH) additive with . inhibitors quinacrine AACOCF3, cyclooxygenase inhibitor indomethacin blocked peptide on PKC, indicating arachidonic its metabolites were involved. This exogenous acid. Prostaglandin acted via EP1 based inhibition SC19220 EP2 since AH6809 had no effect. Like , also phospholipase C-specific beta-1 beta-3 isoforms, delta-1 gamma-1; lysophospholipid decreased [ H]-thymidine incorporation 50% decrease caused In contrast, alkaline phosphatase-specific proteoglycan production a manner similar indicates specific activator chondrocytes, suggests mediates membrane thereby modulating physiological response.

参考文章(71)
J. R. Vane, Y. S. Bakhle, R. M. Botting, CYCLOOXYGENASES 1 AND 2 Annual Review of Pharmacology and Toxicology. ,vol. 38, pp. 97- 120 ,(1998) , 10.1146/ANNUREV.PHARMTOX.38.1.97
BARBARA D. BOYAN, ZVI SCHWARTZ, DAVID L. CARNES,, VIRGINIA RAMIREZ, The Effects of Vitamin D Metabolites on the Plasma and Matrix Vesicle Membranes of Growth and Resting Cartilage Cells in Vitro Endocrinology. ,vol. 122, pp. 2851- 2860 ,(1988) , 10.1210/ENDO-122-6-2851
Franz C. Aepfelbacher, Peter C. Weber, Martin Aepfelbacher, Activation of phospholipase A2 by 1,25 (OH)2 vitamin D3 and cell growth in monocytic U937 and Mono Mac 6 cells. Cell Biochemistry and Function. ,vol. 13, pp. 19- 23 ,(1995) , 10.1002/CBF.290130106
Bomalaski Js, Clark Ma, Fallon M, Turner Ra, Meunier Pc, Crooke St, Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. Journal of Laboratory and Clinical Medicine. ,vol. 116, pp. 814- 825 ,(1990)
A. Kishimoto, Y. Takai, T. Mori, U. Kikkawa, Y. Nishizuka, Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. Journal of Biological Chemistry. ,vol. 255, pp. 2273- 2276 ,(1980) , 10.1016/S0021-9258(19)85886-6
Stephen M. Kelsey, Adrian C. Newland, Xu-Rong Jiang, Paul D. Allen, Yu-Ling Wu, Deborah M. Lillington, 1,25-Dihydroxyvitamin D3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2. Cancer Research. ,vol. 58, pp. 633- 640 ,(1998)